diabetestalk.net

Medtronic Closed Loop Pump Reviews

Highlighting The Revolutionary Medtronic 670g – Features & Reviews

Highlighting The Revolutionary Medtronic 670g – Features & Reviews

The Medtronic MiniMed® 670G System is the world’s first hybrid closed loop insulin pump system, sometimes referred to as an artificial pancreas. The system constantly self-adjusts to automatically keep your sugar levels in range, based on how you live your everyday life. This FDA-approved system is specialized for type 1 diabetes patients, ages 14 and over, and requires a prescription. The Medtronic MiniMed® 670G System is now shipping. 3 New Features that Set the 670G Apart from Earlier Insulin Pumps: 1. Manual Mode – Suspend-before-low option helps you avoid lows and rebound highs proactively by automatically stopping insulin 30 minutes before you reach pre-selected low limits, then automatically restarting insulin when your levels recover (without alerts). 2. Auto Mode – Automatically adjusts basal insulin delivery up and down every 4 minutes, based on your sugar levels, to keep you in target range, all day and night. The system can temporarily change your glucose target during athletic activity to help maintain a safe range. 3. Guardian sensor 3 continuous glucose monitoring sensor – Offers seven-day wear and easy insertion, and is the first and only CGM sensor that is FDA-approved and trusted to control insulin dosing. Other Medtronic MiniMed® 670G System Highlights: Glucose levels are automatically kept within range all night long for a restful, uninterrupted night’s sleep. The system is waterproof, with a bright color screen. At meals and snacks, only check your glucose and enter the number of carbs when you administer a bolus. The 670G system will do the math to regulate your insulin and keep glucose levels in range without any necessary insulin injections. Speaking from Experience Jason Gensler is a person with type 1 diabetes and the founder of th Continue reading >>

Experiencing The Minimed 670g System After 43 Years With Diabetes

Experiencing The Minimed 670g System After 43 Years With Diabetes

In March, we shipped the MiniMed 670G systems to customers in the Customer Training Phase. Among them is Laura, Medtronic Clinical Specialist in Phoenix, Arizona, who has been a part of the Medtronic family – both as a Certified Product Trainer and employee – for 26 years. Today, she shares her experience with the new system. I’ve been on the MiniMed 670G system for a month, and haven’t felt this good in 43 years living with diabetes. I love it! When the FDA approved the MiniMed 670G system, I cried tears of joy. I couldn’t believe this day had finally come. Insulin pumps and continuous glucose monitors (CGM) are a huge part of my personal and professional life. Watching and personally experiencing the advancements in pump and sensor technology has been amazing. My first insulin pump in 1980 weighed a whopping 2.7 pounds (in comparison, the MiniMed 670G system is 1/5 pound)! After 43 years of living with diabetes and 37 years pumping, I’m ecstatic to be on this journey with the world’s first hybrid closed loop system – the MiniMed 670G system! I live an active lifestyle, and no day is the same. For people with diabetes, this means insulin needs vary each day. I love that the MiniMed 670G system understands this – getting to know my insulin needs more every day, and automatically adjusts and personalizes insulin delivery 24 hours a day. I’ve struggled with hypoglycemia unawareness for many years, and the new Suspend before low feature – to me – is a miracle! Suspend before low kept me from going low four times in the three days before I turned on Auto Mode. I didn’t even know I was about to have any lows until I looked at my CareLink report! Starting my day off right and spending more time in range allows me to have more energy and be more produ Continue reading >>

Anyone Using A Minimed 670g?

Anyone Using A Minimed 670g?

Friend T1 in 85, 8ish shots / day (it depends :-) I can only do that only without eating and that doesnt feel marvy D.D. Family T1 41 years, paradigm 522 began 3/08 Gary Schiener published a very comprehensive user review of the 670 highlighting the pump's benefits and shortcomings. I have been on the 670 for 5 months. insulin is just not fast enough to keep blood sugars in an acceptable range on a heavy carb load. The auto mode exists if blood sugars exceed 250 for a period of time. I find many shortcomings with this pump. Loss of use of extended blouses, continuous alarms for one of a myriad of reasons. In my experience, the sensor is nowhere near as accurate as the Dexcom. Eating a lower carb diet is the only way I can control my blood sugars, in my case, less than 75 per day. Some have had better results than I. If insurance will pay 100 percent for the pump, try it out. D.D. Family T1 41 years, paradigm 522 began 3/08 Don't let Medtronic fool you into thinking the 670 will maintain your blood sugar between 70-130. If you are consuming carbs, the insulin action is too slow to keep blood sugars in that range despite the algorithims incorporated into the pump. Auto mode exits when blood sugars exceed 250. The pump, in my case, has not adjusted insulin delivery to avoid lows, below 70. The 670 is first generation closed loop system. I look forward to the programmers continuing to improve the algorithims, and for faster insulin. Even better than technological devices, why not glucose responsive insulin? Even better than technological devices, why not glucose responsive insulin? This is what I'm waiting for and would get truly excited about...smart insulin. Or at least faster acting insulin. But smart insulin would be ideal. I discovered I scream the same way whether I' Continue reading >>

First Impressions Of Medtronic's 670g Hybrid Closed Loop

First Impressions Of Medtronic's 670g Hybrid Closed Loop

Anyone touched by type 1 diabetes has to be excited about the FDA's recent approval of the first pre-Artificial Pancreas system, the Medtronic Minimed 670G. It's a milestone towards ever-more-sophisticated automated insulin delivery! Today, we're thrilled to have our correspondent Wil Dubois walk us through a hands-on initial review of this exciting new system. Test-Driving the Medronic 670G, 'Future of Diabetes Technology' Everything about Medtronic’s new Minimed 670G hybrid closed loop insulin pump is so different that it requires a substantial shift in mindset. Like one of those team-building exercises where you cross your hands and fall backwards, counting on your peers to catch you, the 670G requires us to let go of elements of diabetes control that for years have bordered on sacred. Why? Because this pump isn’t like anything we’ve ever seen before. In fact, it isn’t like any diabetes therapy we’ve ever seen before. What the 670G Does and Doesn't Do How many times have you started your day high, even though you went to bed on-target and haven’t eaten for 8, 10, or more hours? How would you like a pump that could see you were drifting up while you slept, and just automatically gave you more insulin to fix the problem? Or a pump that could see that you are drifting down during a hard day’s work and shut off the flow of insulin to prevent a low? That’s the promise of the 670G. It’s designed to track changes in your blood sugar via a CGM, and keep you in target by automatically delivering “micro boluses” or withholding insulin—replacing a traditional fixed basal rate. All 670G users need to do is count carbs and enter them into the pump when they are going to eat. So, how well does it live up to its promise? Well… OK, first things first. The p Continue reading >>

The Minimed 670g Automatic Glucose Monitor And Insulin Pump For Diabetes

The Minimed 670g Automatic Glucose Monitor And Insulin Pump For Diabetes

Brand name: Minimed 670G System Device Generic Name: Automated Insulin Delivery System Device class: Insulin Pump Manufacturer: Medtronic FDA Approval date: September 28, 2016 On September 28th, 2016, the US Food and Drug Administration approved MiniMed 670G by Medtronic. It is the first FDA-approved device that automatically monitors glucose levels while providing an appropriate basal insulin dose in type 1 diabetics older than 14 years. What is the MiniMed 670G used to treat? MiniMed 670G is a hybrid closed looped system approved by the FDA to treat type 1 diabetes patients ages 14 years or older who require greater than 8 units of basal insulin per day. What is Minimed 670G and how does it work? MiniMed 670G has an integrated SmartGuard technology with an advanced algorithm to simplify and improve diabetes management. It enables greater glucose control with reduced user input. The system includes: the glucose sensor and continuous glucose monitor (CGM) that measures the user’s glucose levels for up to seven days, an insulin pump that delivers insulin, and a glucose meter used for calibration The glucose sensor is inserted under the skin of the abdomen and it measures glucose values in the tissue fluid. The sensor measures blood glucose levels every 5 minutes (interval depends on settings) and the insulin pump automatically administers or withholds basal insulin depending on blood glucose levels and user selected insulin dosing rates. If the glucose level is higher than the preset normal range, then insulin will be delivered following the algorithm. If the glucose level is lower than the preset normal range, the device will withhold insulin administration. Although the device works automatically, the user can also` administer insulin manually to adjust for meals. Th Continue reading >>

Pros & Cons Of The Medtronic Minimed 670g With Guardian

Pros & Cons Of The Medtronic Minimed 670g With Guardian

Our 2018 review Unique Advantages: Pros Large, secure, long-established company Industry leader in R & D Data from Medtronic Guardian CGM displayed on-screen Automatic basal shutoff when low glucose detected by sensor (may help prevent severe hypos) Hybrid closed loop(Automode) basal adjustment based on CGM readings and predictive algorithms High-contrast full-color screen Slim attachable clip Integrated meter serves as remote control for bolusing Frequently used boluses & temp basals can be stored as “presets” Downloadable to online Carelink program Choice of slow or fast bolus delivery Generates insulin/carb/BG statistics “Airplane Mode” option CGM and Automode require additional finger sticks for calibration and safety checks. Maintaining Automode requires a higher level of technical acumen and interaction with the pump. Frequent system alerts in Automode may become intrusive Attached clip is upside-down Must pay for loaner/backup pumps Screen and text are relatively small Insulin-on-board only deducted from correction boluses Downloading restricted to Carelink program Multiple menus and programming can be complex to master Many button-presses and confirmation steps in basic programming Sensor supplies currently on back order until Spring 2018 Delay in getting pumps, supplies and training to new users Company’s marketing can be overly aggressive Continue reading >>

What It’s Like To Use The Medtronic 670g

What It’s Like To Use The Medtronic 670g

Jason Gensler, person with type 1 diabetes, is the founder of the Foundation for Type One Diabetes and the creator of the synergistic philanthropy model. He’s an out of the box thinker, beer aficionado, coffee connoisseur, and bacon fanatic. He proudly dedicates his life to social entrepreneurship on behalf of the global type 1 diabetes community. Jason is one of the first users of the Medtronic 670G hybrid closed loop insulin pump system, sometimes referred to as an artificial pancreas. He’s been wearing the pump for the last 23 months and is planning to help test the next iteration of Medtronic’s technology. He answered some questions for us about what it’s like to live with this promising new device. Tell us a bit about yourself and your experience with diabetes. How old were you when you were diagnosed with type 1 diabetes, and how did you manage your blood sugars before you started the 670G? I was diagnosed with T1D two weeks after my 16th birthday. My 17 year Dia-versary is on May 10th 2017. Prior to the 670G I was wearing the T-slim pump and using the Dexcom G4 CGM. I managed my BGs as best I could prior to the trial and although I could maintain about a 7.0% – 8.0% A1C it felt like a ton of work. What inspired you to sign up to try the 670G? I have participated in many trials over the last 5 years at the Barbara Davis Center, and have witnessed the progress being made in our industry. I went into the 670G pivotal trial with huge expectations, knowing what was on the line for the diabetes industry, our T1D community, and knowing how many companies are pursuing their own version of an artificial pancreas or ‘automated system’. I applaud Medtronic for their efforts to blaze the trail for the industry. In my opinion, they learned a great deal from the Continue reading >>

Medtronic Minimed 670g Auto Mode Review

Medtronic Minimed 670g Auto Mode Review

Type 1 Diabetic striving to get A1C below 7 Earlier this year, Medtronic released their new insulin pump/CGM system called the Minimed 670G , the worlds first hybrid closed loop system. The hybrid closed loop system basically means that a CGM communicates with your insulin pump and if it sees your blood sugar rising, it will give small micro-boluses every 5 minutes. If it sees your blood sugar going down, it will hold off on the micro-boluses. The system aims to have a blood sugar of 120 mg/dls but will only correct a high blood sugar to 150 mg/dls if its correcting a high. The blue shield means Im in auto mode on the 670G I have been on auto mode for 2 months now. Overall, I LOVE it and would highly recommend the Medtronic 670G! It is a new way of thinking about pumping and it takes some time for the pump to learn you. The first week on auto mode was ROUGH.I had so many highs and lows it was crazy. I felt like I was on a never ending roller coaster ride. As the pump was learning me, I was also learning how to use the new pump as well. When I would go low, I would have to be patient and know that the pump was making adjustments so I didnt need to correct with as many carbs as I usually did. I was also frustrated at not being able to correct a high when I wanted to. On auto mode, you arent able to do a correction bolus unless it tells you to. The first week when I was high, I would be frustrated when I couldnt bolus for a high that sometimes I would do a phantom carb entry, meaning I would bolus for about 10 carbs so that it would give me some extra insulin. However, this hinders the pump to learn you so I only did it a couple of times and waited patiently for the pump to learn me. In addition to the highs and lows, I was finding it to be a lot more work initially. I ha Continue reading >>

Hybrid Closed Loop System.

Hybrid Closed Loop System.

NEW! The Suspend before low§ option avoids lows and rebound highs proactively by automatically stopping insulin 30 minutes before you reach your pre-selected low limits, then automatically restarts insulin when your levels recover, all without bothersome alerts. NEW! The Auto Mode‡ option automatically adjusts your basal insulin delivery every 5 minutes based on your sugar levels to keep you in target range, all day and night. Watch Video View Brochure Get Started NEW! Guardian® Sensor 3 continuous glucose monitoring sensor. Introducing the most accurate sensor from Medtronic, now with up to 7 day wear and easy insertion. It is the FIRST and ONLY continuous glucose monitoring sensor FDA approved and trusted to control insulin dosing. Exclusive CONTOUR®NEXT LINK 2.4 meter1 Get easy and accurate CGM calibration, insulin dosing and remote bolusing with our exclusive meter. “This device will mean peace of mind, in knowing a person will be in normal blood sugar range a great majority of the time,” “It’s a medical device with the potential to change the lives of more than 1 million Americans who suffer from Type 1 diabetes.” KEEP YOUR GLUCOSE IN RANGE SMARTGUARD® HCL TECHNOLOGY. Quick and easy access to your glucose and insulin information, all from the home screen. Bright color screen for easy readability - day or night. Waterproof - so you can enjoy underwater activities. Quick and easy bolus from your meter. Fewer shots than multiple daily injections. The only sensor FDA approved and trusted to control insulin dosing. Easy to insert. Know at all times where your glucose levels are trending. Click here for assistance if your insurance does not currently cover the MiniMed 670G system. * Mean Absolute Relative Difference. ** 3-4 calibrations per day required. Continue reading >>

2018 New Insulin Pump Comparisons And Reviews

2018 New Insulin Pump Comparisons And Reviews

Insulin pumps are NOT commodities. There are differences between systems (some subtle, some obvious) that make certain pumps better options for certain individuals. It is astounding that so many people are given little to no choice when it comes to selecting an insulin pump. Given that pump warranties last longer than the average marriage, it makes sense to invest some time in comparing the various devices before making a selection. Every member of our clinical team has personal and professional experience with every make and model of insulin pump. We are not employed by any pump company, and we are not easily pressured (although really good chocolate has been known to sway our opinion a bit), so we can offer you fair and impartial information/insight. Please use our pump comparisons to help make an educated decision. We have listed the positive and negative features that are unique to each pump. Features that are common to all pumps, such as allowing for multiple basal patterns, are not included. At the end of the day, the choice is yours. If you would like some expert input, feel free to contact our office and schedule some time to meet or speak with one of our clinicians. And for assistance applying your pump to achieve the best possible glucose management, please reach out. Continue reading >>

Medtronic’s Minimed 670g Hybrid-closed Loop – Exclusive Interview With 17-year-old Trial Participant

Medtronic’s Minimed 670g Hybrid-closed Loop – Exclusive Interview With 17-year-old Trial Participant

By Adam Brown and Alexander Wolf Twitter Summary: We interview #T1D patient from @MDTDiabetes 670G hybrid closed loop clinical trial @Stanford Josh Airth, a 17-year old with type 1 diabetes, recently participated in a clinical trial of the Medtronic 670G “hybrid-closed loop” system (insulin pump + Enlite 3 CGM sensor). We had the opportunity to ask Josh questions about his experience on the 670G, which is the first direct patient testimony we’ve heard so far about this innovative technology. As a reminder, we learned in January that Medtronic hopes to launch this pump and CGM system in the US by April 2017 – a lot of things will have to go right to reach this goal, that is for sure! Based on the Enlite 3 CGM reading every five minutes, the 670G pump’s software automatically increases/decreases basal insulin delivery to target a blood glucose of 120 mg/dl. The 670G algorithm is fully integrated within the pump itself, so a patient only needs to wear the Enlite 3 CGM sensor and the MiniMed 670G pump – no need to carry a separate CGM receiver. One last important point: the 670G is considered a “hybrid-closed loop,” as a user still needs to bolus for meals and notify the system of exercise. Otherwise, it mostly takes care of insulin dosing in the background, which is particularly valuable at night. The clinical trial took place in a “study house” near Stanford University, where five adolescent participants wore the 670G for three days and three nights under the supervision of a research team. For safety, participants also carried a small box (“Carelink Connect”) around, which wirelessly sent all the information from the pump to a website monitored by the researchers. Otherwise, the trial was fairly real world, allowing participants to eat and move as Continue reading >>

Medtronic Minimed 670g System Review

Medtronic Minimed 670g System Review

After months of waiting, I finally received the world’s first hybrid closed loop system, the Minimed 670G system. Medtronic’s Minimed 670G system is an insulin pump and continuous glucose monitor that also has technology to put you in “auto” mode where it will automatically adjust your basal insulin every 5 minutes based on your blood sugar levels. I’ve had the system for about two weeks now so I thought I’d share my thoughts on it. I’m going to break this down into two posts because I feel the auto mode review needs it’s on page. I’ve been with Medtronic and on an insulin pump since 1997, 20 years! For most of the 20 years, the insulin pump has looked the exact same. It has “mainly” had the same features and not a lot of technology advancements. This new pump, however, is completely different than anything Medtronic has released in the last 20 years, with one caveat that they did release the Minimed 630G a few months prior. I received the Minimed 630G as part of the Minimed 670G Priority Access Group. In case you weren’t aware, Medtronic released a new pump, the 630G, last year and a few weeks (or months, not positive on the timing), the FDA approved their 670G pump faster than they realized. To not waste all the millions of dollars they probably spent on the 630G, they started a Priority Access Group for the 670G where you had to get the 630G first and then once the 670G was released, you could be the first to get it. The stars aligned for me where my pump went out of warranty last year and I had reached my out of pocket max because of the birth of my baby, so I was able to get the 630G for free! I never did use the 630G though because the new design of the pump sort of scared me and I was happy with my old pump. Because I never used the 630G, Continue reading >>

Medtronic’s Minimed 670g Hybrid Closed Loop: 1,500-person Study!

Medtronic’s Minimed 670g Hybrid Closed Loop: 1,500-person Study!

Comparing Medtronic’s MiniMed 670G to injections and pumps in people with type 1 diabetes, with and without CGM; enrollment to open in May at some trial locations Clinical Trials Identifier: NCT02748018 Trial name: Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home Diabetes type: Type 1 diabetes What it’s testing: This research study will test the safety and effectiveness of the MiniMed 670G hybrid closed loop system compared to multiple daily injections, an insulin pump without continuous glucose monitoring (CGM), and an insulin pump with CGM. What the trial is measuring: Researchers will mainly look at A1c levels, the number of severe hypoglycemia episodes, and the number of DKA episodes over a six-month period. They will also look at time spent with a blood sugar below 70 mg/dl and time spent in-range (70-180 mg/dl). Why this is new/important: Medtronic’s MiniMed 670G is a hybrid closed loop system, consisting of an insulin pump (with tubing), a continuous glucose monitoring (CGM) sensor inserted under the skin, and a transmitter worn on the body. When the 670G is operating in “Auto Mode,” it receives a glucose value from the CGM every five minutes and uses it to automatically adjust basal insulin delivery, targeting a blood glucose level of 120 mg/dl. The 670G is the first and only approved “hybrid closed loop” system in the US, having received FDA approval in September 2016. This approval was based on a short three-month study without a control group, which showed that the 670G is safe. However, as a condition of the approval, Medtronic has to conduct a larger study to provide additional outcomes data. The 670G has already begun a controlled launch (Customer Training Phase), with a broader l Continue reading >>

670g And Me: Insights And Incites On Medtronic’s Latest System

670g And Me: Insights And Incites On Medtronic’s Latest System

What’s the purpose of a diabetes management device? Is it to lower A1c? Prevent hypoglycemia? Spend more time in-range? Some combination of all three? Or perhaps we have to look beyond blood sugar control. After all, quality of life has to count for something. Does it make living with diabetes safer and easier? My Detailed Review of The MiniMed 670G from Medtronic The MiniMed 670G from Medtronic is an insulin pump coupled with a glucose sensor. It uses a computer program (called an “algorithm”) to automate certain aspects of insulin delivery. I decided to try 670G partially out of professional interest (everybody and their great aunt has been asking for my opinion on the system), and partially out of personal interest, as my blood glucose control hasn’t been the greatest the past couple of years. Let me start out by saying this: Since I started using 670G, my overall blood glucose control is better. I have to keep reminding myself of this non-consequential fact, because every day I find things about this system that I don’t particularly like. In my opinion, the pump itself leaves a lot to be desired. There are so many features and so many menus and so many safety/confirmation steps that my button thumb is starting to form a blister. The color screen is nice, but not large enough to display everything it needs to display. And the freakin’ clip is upside down. The reservoir connector pokes me in the gut every time I bend over, and I have to unclip it to see the screen and programming menus in the proper orientation. The “hybrid closed loop” part of the system (what I prefer to call the “semi-automatic feature”) is what makes 670G special. It functions by making adjustments to the BASAL insulin based on data received from the linked glucose sensor. Sinc Continue reading >>

My New Boyfriend, The Medtronic 670g

My New Boyfriend, The Medtronic 670g

I have been a bit quiet lately, and that is mostly because I have wanted to give the 670G a chance with out diving in with posts. That, and I simply haven’t had time. I am happily busy with work and raising a family, which is what currently occupies most of my attention. So, I started on the 670G on August 1st, and stayed in manual mode for 2 weeks. I believe that helped me a lot, especially since the 670G works differently than even the 630G. However, even from starting on the 670G, things were getting better. This is because the pump suspends insulin before I hit my low limit, AND it stays off only as long as I need it to. SO, If I only needed it paused for 30 minutes, that’s all it would suspend for, and my basal would be automatically resumed. (Unlike the 530G and 630G where it would stay on for the full 2 hours and stay that way). So right away, my rebounds were so much smoother, and I could treat with less carbs. I have to admit — I was super scared going into auto mode. I seriously didn’t think I wanted to even use it. But, I went in and went through with it, and I’m so glad I did. Now — here is where the title reference comes in. While I was at AADE, I talked with a Medtronic rep for a long time about auto mode. She told me the best advice she has been able to give her patients is to look at the system like starting a brand new relationship. ( I mean, what first date doesn’t try to “sell” you and exaggerate their features a bit teensy when you meet them?) You have to give it time and patience. With that in mind, and comments from others to say that it takes about a month to three months to get the system adjusted to you, I didn’t go into it with expectations that flipping me over to auto mode would be a cruise-control switch, because it’s n Continue reading >>

More in insulin